Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Intensive Care Medicine
Erschienen in: Intensive Care Medicine 9/2006

01.09.2006 | Special Article

Acute lung injury and the coagulation pathway: potential role of gene polymorphisms in the protein C and fibrinolytic pathways

verfasst von: Anil Sapru, Joseph L. Wiemels, John S. Witte, Lorraine B. Ware, Michael A. Matthay

Erschienen in: Intensive Care Medicine | Ausgabe 9/2006

Einloggen, um Zugang zu erhalten

Abstract

There is evidence that dysregulation of coagulation and fibrinolysis may participate in the pathogenesis of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS). Altered concentrations of several proteins of the coagulation and fibrinolytic pathways in plasma and pulmonary edema fluid from patients with acute lung injury have been related to the severity of lung injury and clinical outcomes. Polymorphisms in the genes encoding for proteins of the protein C and fibrinolysis pathways are known to regulate the production of the respective proteins. It is plausible that these polymorphisms may be associated with the susceptibility to and severity of illness in ALI and ARDS. Well-designed studies that examine the association of these polymorphisms with susceptibility and severity of ALI and ARDS are needed to test the influence of both genetic and environmental factors on the clinical outcomes in patients with ALI and ARDS. There are several important considerations in the design of these genetic association studies, including selection of candidate genes with the most biological plausibility, definition of the phenotype, selection of appropriate controls, determination of the appropriate sample size and assessment of Hardy–Weinberg equilibrium among controls as a measure of internal validity.
Literatur
1.
Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 167:1027–1035PubMedCrossRef
2.
Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–1693PubMedCrossRef
3.
Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51–61PubMedCrossRef
4.
Flori HR, Glidden DV, Rutherford GW, Matthay MA (2005) Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 171:995–1001PubMedCrossRef
5.
Villar J (2002) Genetics and the pathogenesis of adult respiratory distress syndrome. Curr Opin Crit Care 8:1–5PubMedCrossRef
6.
Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264PubMedCrossRef
7.
Paparella D, Brister SJ, Buchanan MR (2004) Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 30:1873–1881PubMedCrossRef
8.
Amaral A, Opal SM, Vincent JL (2004) Coagulation in sepsis. Intensive Care Med 30:1032–1040PubMedCrossRef
9.
Idell S (2002) Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med 30:S274–280PubMedCrossRef
10.
Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA Jr (1990) Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890–897PubMedCrossRef
11.
Su X, Camerer E, Hamilton JR, Coughlin SR, Matthay MA (2005) Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 175:2598–2605PubMed
12.
Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T (2004) Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59:130–135PubMedCrossRef
13.
Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W (2000) Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161:454–462PubMed
14.
Vadasz I, Morty RE, Olschewski A, Konigshoff M, Kohstall MG, Ghofrani HA, Grimminger F, Seeger W (2005) Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase. Am J Respir Cell Mol Biol 33:343–354PubMedCrossRef
15.
Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay MA (2002) Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 346:1281–1286PubMedCrossRef
16.
Prudhomme J.B, Wang L, Wickersham N, Matthay M.A, Ware L.B (2005) Tissue factor levels in ARDS are 100-fold higher in edema fluid compared to plasma and correlate with mortality. Proc Am Thoracic Soc 2:A826
17.
Van de Wouwer M, Collen D, Conway EM (2004) Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 24:1374–1383PubMedCrossRef
18.
Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ (2003) Expression and function of the endothelial protein C receptor in human neutrophils. Blood 102:1499–1505PubMedCrossRef
19.
Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878–3885PubMedCrossRef
20.
Ware LB, Fang X, Matthay MA (2003) Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L514–521PubMed
21.
Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA (2003) Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L20–28PubMed
22.
Ware LB, Eisner M, Wickersham N, Olman MA, Thompson B, Parsons P, Matthay MA (2004) Plasminogen activator inhibitor-1 (PAI-1), a marker of impaired fibrinolysis, is associated with higher mortality in patients with ALI/ARDS. Am J Respir Crit Care Med 169:A115
23.
Ware LB, Ancukiewicz M, Parsons PI, Matthay MA (2003) Prognostic value of plasma protein C in patients with acute lung injury. Am J Respir CritCare Med 167:A661
24.
Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ (1982) Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124–130PubMedCrossRef
25.
Hudson LD, Milberg JA, Anardi D, Maunder RJ (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293–301PubMed
26.
Kleeberger SR, Reddy S, Zhang LY, Jedlicka AE (2000) Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol 22:620–627PubMed
27.
Leikauf GD, McDowell SA, Wesselkamper SC, Hardie WD, Leikauf JE, Korfhagen TR, Prows DR (2002) Acute lung injury: functional genomics and genetic susceptibility. Chest 121:70S–75SCrossRef
28.
Grigoryev DN, Finigan JH, Hassoun P, Garcia JG (2004) Science review: searching for gene candidates in acute lung injury. Crit Care 8:440–447PubMedCrossRef
29.
Currier PF GM, Pothier LJ, Boyce PD, Thompson BT, Christiani DC (2005) Surfactant protein-B polymorphism is associated with increased mortality at 28 days in ARDS patients. Proc Am Thoracic Soc 2:A243CrossRef
30.
Wattanathum A, Manocha S, Groshaus H, Russell JA, Walley KR (2005) Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest 128:1690–1698PubMedCrossRef
31.
Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Umberto Meduri G, Shriver MD, Ingersoll R, Scott AF, Beaty TH, Moitra J, Ma SF, Ye SQ, Barnes KC, Garcia JG (2006) Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 1044–1549
32.
Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, Nukiwa T (2004) Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 126:95–99PubMedCrossRef
33.
Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC (2004) Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 125:203–211PubMedCrossRef
34.
Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, Boyce P, Christiani DC (2005) -308GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J 26:382–389PubMedCrossRef
35.
Gong MN ZW, Pothier L, Thompson BT, Christiani DC (2005) Mannose-binding lectin polymorphisms and ARDS. Proc Am Thoracic Soc 2:A243CrossRef
36.
Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, Floros J (2000) Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 58:181–191PubMedCrossRef
37.
Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ (2002) Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 166:646–650PubMedCrossRef
38.
Medford AR, Keen LJ, Bidwell JL, Millar AB (2005) Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax 60:244–248PubMedCrossRef
39.
Quasney MW, Waterer GW, Dahmer MK, Kron GK, Zhang Q, Kessler LA, Wunderink RG (2004) Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 32:1115–1119PubMedCrossRef
40.
Ye SQ, Simon BA, Maloney JP, Zambelli-Weiner A, Gao L, Grant A, Easley RB, McVerry BJ, Tuder RM, Standiford T, Brower RG, Barnes KC, Garcia JG (2005) Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 171:361–370PubMedCrossRef
41.
Wunderink RG, Waterer GW, Cantor RM, Quasney MW (2002) Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. Chest 121:87SCrossRef
42.
Russell JA (2003) Genetics of coagulation factors in acute lung injury. Crit Care Med 31:S243–247PubMedCrossRef
43.
Rebbeck TR, Spitz M, Wu X (2004) Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5:589–597PubMedCrossRef
44.
Aiach M, Nicaud V, Alhenc-Gelas M, Gandrille S, Arnaud E, Amiral J, Guize L, Fiessinger JN, Emmerich J (1999) Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 19:1573–1576PubMed
45.
Arnaud E, Barbalat V, Nicaud V, Cambien F, Evans A, Morrison C, Arveiler D, Luc G, Ruidavets JB, Emmerich J, Fiessinger JN, Aiach M (2000) Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Temoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol 20:892–898PubMed
46.
Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354:556–560PubMedCrossRef
47.
Hoekstra T, Geleijnse JM, Schouten EG, Kluft C (2004) Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost 91:861–872PubMed
48.
Norlund L, Holm J, Zoller B, Ohlin AK (1997) A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost 77:248–251PubMed
49.
Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S (2004) A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 103:1311–1318PubMedCrossRef
50.
Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM (2004) Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2:1305–1310CrossRef
51.
Endler G, Mannhalter C (2003) Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 330:31–55PubMedCrossRef
52.
Kottke-Marchant K (2002) Genetic polymorphisms associated with venous and arterial thrombosis: an overview. Arch Pathol Lab Med 126:295–304PubMed
53.
Lane DA, Grant PJ (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:1517–1532PubMed
54.
Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851–1855PubMedCrossRef
55.
Henry M, Tregouet DA, Alessi MC, Aillaud MF, Visvikis S, Siest G, Tiret L, Juhan-Vague I (1998) Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol 18:84–91PubMed
56.
McCormack LJ, Semple JI, Stickland MH, Barrett JH, Grant PJ (1998) The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells. Thromb Res 92:199–206PubMedCrossRef
57.
Barnes KC (2005) Genetic determinants and ethnic disparities in sepsis-associated acute lung injury. Proc Am Thorac Soc 2:195–201PubMedCrossRef
58.
Khadaroo RG, Marshall JC (2002) ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process. Crit Care Clin 18:127–141PubMedCrossRef
59.
Rubenfeld GD, Christie JD (2004) The epidemiologist in the intensive care unit. Intensive Care Med 30:4–6PubMedCrossRef
60.
Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2:91–99PubMedCrossRef
61.
Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405:847–856PubMedCrossRef
62.
Romero R, Kuivaniemi H, Tromp G, Olson J (2002) The design, execution, and interpretation of genetic association studies to decipher complex diseases. Am J Obstet Gynecol 187:1299–1312PubMedCrossRef
63.
64.
Browner W (2001) Estimating sample size. In Browner W, Newman T, Cummings S, Hulley S (eds) Designing clinical research: an epidemiologic approach. Lippincott Williams & Wilkins, Philadelphia, p 75
65.
Newton-Cheh C, Hirschhorn JN (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res 573:54–69PubMed
66.
Lyon H, Lange C, Lake S, Silverman EK, Randolph AG, Kwiatkowski D, Raby BA, Lazarus R, Weiland KM, Laird N, Weiss ST (2004) IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol 26:155–165PubMedCrossRef
67.
Ozturk A, Dekosky ST, Kamboh MI (2005) Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiol Aging DOI: 10.10.16/j.neurobiolaging.2005.08.02.4
68.
Prince JA, Feuk L, Gu HF, Johansson B, Gatz M, Blennow K, Brookes AJ (2003) Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 22:363–371PubMedCrossRef
69.
Wanic K, Malecki MT, Wolkow PP, Klupa T, Skupien J, Bobrek J, Kozek E, Krolewski AS, Sieradzki J (2006) Polymorphisms in the gene encoding hepatocyte nuclear factor-4alpha and susceptibility to type 2 diabetes in a Polish population. Diabetes Metab 32:86–88PubMedCrossRef
70.
Mattevi VS, Zembrzuski VM, Hutz MH (2006) Impact of variation in ADRB2, ADRB3, and GNB3 genes on body mass index and waist circumference in a Brazilian population. Am J Hum Biol 18:182–186PubMedCrossRef
71.
Silverman EK, Palmer LJ (2000) Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 22:645–648PubMed
72.
Morrison J, Gauderman J (2004) Quanto, accessed at http://hydra.usc.edu/GxE/
73.
74.
Carlson CS, Eberle MA, Kruglyak L, Nickerson DA (2004) Mapping complex disease loci in whole-genome association studies. Nature 429:446–452PubMedCrossRef
75.
Crawford DC, Carlson CS, Rieder MJ, Carrington DP, Yi Q, Smith JD, Eberle MA, Kruglyak L, Nickerson DA (2004) Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am J Hum Genet 74:610–622PubMedCrossRef
76.
Crawford DC, Nickerson DA (2005) Definition and clinical importance of haplotypes. Annu Rev Med 56:303–320PubMedCrossRef
77.
Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279–284PubMedCrossRef
78.
Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945–959PubMed
79.
Kohler K, Bickeboller H (2006) Case-control association tests correcting for population stratification. Ann Hum Genet 70:98–115PubMedCrossRef
80.
Devlin B, Roeder K, Wasserman L (2001) Genomic control, a new approach to genetic-based association studies. Theor Popul Biol 60:155–166PubMedCrossRef
81.
Bacanu SA, Devlin B, Roeder K (2000) The power of genomic control. Am J Hum Genet 66:1933–1944PubMedCrossRef
82.
Gong MN, Thompson BT, Williams PL, Zhou W, Wang MZ, Pothier L, Christiani DC (2006) Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J 27:674–681PubMedCrossRef
Metadaten
Titel
Acute lung injury and the coagulation pathway: potential role of gene polymorphisms in the protein C and fibrinolytic pathways
verfasst von
Anil Sapru
Joseph L. Wiemels
John S. Witte
Lorraine B. Ware
Michael A. Matthay
Publikationsdatum
01.09.2006
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 9/2006
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-006-0223-5

Weitere Artikel der Ausgabe 9/2006

Intensive Care Medicine 9/2006 Zur Ausgabe

Original

Point of care management of heparin administration after heart surgery

Correspondence

Air ionisation and colonisation/infection with methicillin-resistant Staphylococcus aureus and Acinetobacter species in an intensive care unity: a reply to Jeffers

Original

Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock

Correspondence

Reply to the comment by Dr. Kevin

Correspondence

Reply to “Organ donation in pediatric traumatic brain injury” by Morris et al.

Correspondence

Discordant response to ACTH stimulation in patients with septic shock

Neu im Fachgebiet AINS

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Schlaganfall: frühzeitige Blutdrucksenkung im Krankenwagen ohne Nutzen

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise